Funding

Vida generates $600m, triples assets to expand life sciences platform

08-Aug-2019 By Vassia Barba

Vida announced the closure of its second fund, which generated $600m to be invested in the further expansion of its life sciences platform.

EQT VIII Fund invests in Aldevron, supports capacity expansion

07-Aug-2019 By Vassia Barba

EQT VIII Fund set to acquire majority interest in plasmid DNA supplier Aldevron, announces investments to support the expansion of its production capacity.

‘Not business as usual at FDA’: Only addressing immediate threats due to shutdown

15-Jan-2019 By Maggie Lynch

The US FDA is faced with lapsed funding appropriations as the US government shutdown continues, causing the agency to focus on addressing immediate threats to consumer safety.

BIO EUROPE 2018

Building a biotech in EU vs US: ‘It all boils does to the access of capital,’ says CEO

28-Nov-2018 By Flora Southey

It is more difficult and time-intensive to develop a successful biotech in Europe than in the US, says CEO.

Infographic: Record year for ANDA approvals in US

26-Oct-2018 By Maggie Lynch

The US FDA reached a record number of generic ANDAs last financial year, ending September 2018.